FDA Investigator Laurimer Kuilan Torres

Laurimer Kuilan Torres has inspections in 9 countries as of 28 Sep 2023. Laurimer Kuilan Torres has collaborated with a combinined 5018 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
68
Last Inspection Date:
28 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China, Japan, India, Israel, United States of America, Czechia, Mexico, Canada
Co-Investigator(s):
Abby Lmozeke Baker, Ademola O Daramola, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, Anastasia M Shields, Angela E Glenn, Angelica M Hernandez, Ann L Demarco, Annette Melendez, Anthony A Charity, Ariel Cruz Figueroa, Arlene M Badillo, Arwa S El Hagrasy, Ashar P Parikh, Aurora Miha Trifanov, Azza Talaat, Bingchen Du, Binh T Nguyen, Brenda Rivera, Brian D Nicholas, Brian D Nicholson, Brian J Ryan, Brian L Belz, Brooke K Higgins, Bruce H Mccullough, Carlos A Medina, Carr Sharpe, Carrie L Doupnik, Cassandra L Abellard, CDR Ileana Barreto Pettit, Cecilia H Kieu, Charisse K Green, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Christina A Miller, Christina Capacci Daniel, PhD, Christopher D Leach, Christopher M Jenner, Christopher S Keating, Cynthia J Lee, MS, Cynthia Jim, CSO, David J Gomes, David L Chon, Dayna I Martinez, Debra I Love, Dennis Cantellops Paite, Diane L Raccasi, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Donald L Lech, Donna Christner, Dr. Gang Wang, PhD, Edmund F Mrak, Jr, Edwin Martinez, Eileen A Liu, Eric L Dong, BS, Erika E Englund, PhD, Eva I Merced Medina, Farhana Khan, Felix Maldonado, Francis A Guidry, Frank J Marciniak, Gavin T Cua, George Pyramides, German Rivera, Hala L Selby, Hector J Colon Torres, Helen Verdel, Holly Brevig, Iraida Ortiz, Ivis L Negron, Ivis Lnegron Torres, Jacob G Lutz, Jaime E Pares, James W Plucinski, Javier O Vega, Jeremy W Rotton, Jesse A Vazquez, Joan Cantellops Figueroa, Joan M Cantellops Figueroa, Joel D Hustedt, Joey V Quitania, John A Gonzalez, Jonathan G Matrisciano, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Cruz, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, José E Meléndez, Jose E Melendez, DDC, Jose Fpedrode Jesus, Jose Martinez, Jr, Jose Melendez, Jose Perez Soto, Jose R Hernandez, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Joseph A Morkunas, Joshua M Adams, Juanita P Versace, Judy C Nepsa, Justin A Boyd, Karl D Hezel, Katherine Szestypalow, Kathleen R Jones, PhD, Kevin A Gonzalez, Kham Phommachanh, Krishna Ghosh, PhD, Kristy A Zielny, Kristy E Zuroski, Kumar G Janoria, Laiza V Garcia, Lane Christensen, PhD, Lane V Christensen, PhD, Lareese K Thomas, Larry K Austin, Latorie S Jones, Laura E Garcia, Laurie B Frazier, Laurimer Kuilan, Leslie A Mendoza, Libia M Lugo, Liming Zhang, Linda Thai, Lindsey M Schwierjohann, Lisa Hayka, Lisa Hornback, Lisa M Lopez, Lisa R Whitt, Lloyd D Payne, Loreily Figueroa, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, LT Richard A Lyght, Lucas B Leake, Luis A Dasta, Luis Soto Lopez, Lydia S Chan, Marcus A Ray, Margaret M Annes, Margarita Santiago, Maria G Gutierrez Hoffman, Maria Gutierrez Hoffman, PhD, Marian E Ramirez, Marianela Aponte Cruz, Marijo B Kambere, PhD, Marilyn Santiago, Marvin D Jones, Massoud Motamed, Matthew B Casale, Matthew C Watson, Matthew J Johnson, Maya M Davis, Meisha R Sampson, Meisha Waters, Merry Christie, PhD, Michael A Charles, Michael A Taylor, Michael E Maselli, Michael L Chasey, Michael Levy, Michael R Goga, Michael R Klapal, Miguel A Martinez, Milva E Melendez, Monica E Caphart, Mra Davism, Mra Mcculloughj, Muna Algharibeh, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy Rosado, Nebil A Oumer, Neisa M Alonso, Nibin Varghese, MS, Nicholas A Violand, Nicholas L Hunt, Nicholas P Diorio, Nicole E Knowlton, Nimmy Mathews, Noreen Muniz, Noreen Muñiz, Pablo Feliciano, Parul M Patel, Patricia A Mcilroy, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Peter E Baker, Rachael A Moliver, Rafael Nevarez Nieves, Rafael Padilla, Ramesh Potla, PhD, Ramon A Hernandez, Randall N Johnson, Randy L Clarida, Rapti D Madurawe, Raquel Gonzalez, Raquel Gonzalez Rivera, Raymond T Oji, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Robert J Doyle, Rochelle A Rolnik, Roger F Zabinski, Rong Wang, PhD, Rozelle G Smith, Russell K Riley, S Lori Brown, PhD MPH, Saied A Asbagh, Saleem A Akhtar, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Sarah E Mcmullen, Satheesh Thomas, Scott J Matsuda, Scott T Ballard, Sharmista Chatterjee, Simone E Pitts, Sixto M Mercado, Sixto M Mercado Rios, Sonia M Monges, Sony Mathews, Stacie A Woods, State Agency, Stefen D Mcmillan, Stephanie A Slater, MS, Stephanie D Crockett, Stephen D Eich, Steven D Kehoe, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Sumit Sen, Sunitha K Rajaram, PhD, Susan P Bruederle, Susan W Ting, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Suzanne N Vallez, Syed N Ali, That Q Dang, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tonia F Bernard, Tracy Denison, PhD, Truong Xuan Nguyen (Andy), Vaishali J Patel, Victor S Pacheco, Vidya B Pai, Vilmary Negron Rodriguez, Vincent Thomas, Virgilio F Pacio, CSO, Walden H Lee, Wendy G Tan, PhD, Wenzheng Zhang, William A Warnick, Xiaokuang Lai, PhD, Yeissa Chabrier Rosello, Ying Zhang, Yvins Dezan, Zachary A Bogorad, Zachary L Stamm

Laurimer Kuilan Torres's Documents

Publish Date Document Type Title
November, 2015 EIR Precision Nuclear of Virginia, LLC - EIR, 2015-11-19
August, 2017 FDA 483 Fenwal International, Inc. - Form 483, 2017-08-22
April, 2019 FDA 483 Zhejiang Tianyu Pharmaceutical Co., Ltd. - Form 483, 2019-04-12
February, 2017 FDA 483 Ajanta Pharma Limited - Form 483, 2017-02-07
December, 2018 FDA 483 Baxter Healthcare Corporation - Form 483, 2018-12-21
September, 2019 FDA 483 Hangzhou Linkeweier Daily Chemicals Co., Ltd. - Form 483, 2019-09-17
May, 2015 EIR Auro PR Inc. - EIR, 2015-05-22
December, 2018 EIR Baxter Healthcare Corporation - EIR, 2018-12-21
November, 2019 FDA 483 Jianerkang Medical Co., Ltd - Form 483, 2019-11-01
April, 2019 FDA 483 Response Bloomage Biotechnology corp., Ltd. - Form 483R, 2019-05-17
June, 2019 FDA 483 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. - Form 483, 2019-06-13
April, 2019 FDA 483 Bloomage Biotechnology corp., Ltd. - Form 483, 2019-04-26
December, 2018 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2019-01-16
July, 2016 FDA 483 Pharmalogic Puerto Rico, Inc. - Form 483, 2016-07-22
March, 2022 FDA 483 Zhejiang Tianyu Pharmaceutical Co., Ltd. - Form 483, 2022-03-04
October, 2016 FDA 483 Auro PR Inc. - Form 483, 2016-10-24
April, 2019 FDA 483 Response Zhejiang Tianyu Pharmaceutical Co., Ltd. - Form 483R, 2019-05-03
May, 2015 FDA 483 Auro PR Inc. - Form 483, 2015-05-22
June, 2018 FDA 483 IPR Pharmaceuticals, Inc - Form 483, 2018-06-14
November, 2019 FDA 483 Zhejiang Regen Chemical Co., Ltd. - Form 483, 2019-11-25
September, 2022 FDA 483 Smith & Nephew Wound Management - Form 483, 2022-09-30
July, 2021 EIR Zhejiang Huahai Pharmaceutical Co., Ltd. - EIR, 2021-07-29
June, 2017 FDA 483 Apotex Inc. - Form 483, 2017-06-14
July, 2019 FDA 483 Excellence Medical Supplies Co., Ltd. - Form 483, 2019-07-12
November, 2015 FDA 483 Response Precision Nuclear of Virginia, LLC - Form 483R, 2015-12-09
May, 2016 FDA 483 Janssen Ortho LLC - Form 483, 2016-05-18
May, 2015 FDA 483 Janssen Ortho LLC - Form 483, 2015-05-29
October, 2015 FDA 483 Cardinal Health 414, LLC - Form 483, 2015-10-16
April, 2022 FDA 483 Yabao Pharmaceutical Co., Ltd. Beijing - Form 483, 2022-04-20
October, 2021 FDA 483 Tianjin Asymchem Pharmaceuticals Co., Ltd. - Form 483, 2021-10-19
February, 2018 FDA 483 TEENA BIOLABS PRIVATE LIMITED - Form 483, 2018-02-09
April, 2019 EIR Bloomage Biotechnology corp., Ltd. - EIR, 2019-04-26
June, 2018 FDA 483 Response IPR Pharmaceuticals, Inc - Form 483R, 2018-07-05
June, 2016 FDA 483 Medefil, Inc. - Form 483, 2016-06-17
April, 2019 EIR Zhejiang Tianyu Pharmaceutical Co., Ltd. - EIR, 2019-04-12
November, 2018 FDA 483 Ex-Lax, Inc. - Form 483, 2018-11-05
March, 2017 FDA 483 Teva Czech Industries s.r.o - Form 483, 2017-03-24
June, 2023 FDA 483 FUJIFILM Diosynth Biotechnologies Texas, LLC - Form 483, 2023-06-07
May, 2023 FDA 483 Takeda Pharmaceutical Company Limited - Form 483, 2023-05-24
July, 2016 FDA 483 Pharmalogic Puerto Rico, Inc. - Form 483, 2016-07-22
July, 2016 EIR Pharmalogic Puerto Rico, Inc. - EIR, 2016-08-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more